Kinovate Life Sciences Launches Carrigene® Plates for in Vitro Transfection of Plasmid DNA
Complete the form below to unlock access to ALL audio articles.
Kinovate Life Sciences, Inc has announced that it will officially launch CarriGene® Plates - a fast transfection plate product for in vitro delivery of plasmid DNA to mammalian cells.
CarriGene® Plates will be available in 6, 12, 24-well and 10 cm dish formats for routine transfection and viral vector production, as well as the 96-well format for high throughput screening applications.
The Plates are pre-coated with Kinovate’s biodegradable cationic polymer transfection reagent, which delivers high transfection efficiency across a broad range of mammalian cell lines with low toxicity.
This patented technology offers a DNA transfection reagent pre-coated onto plates. Using this format, researchers are able to simplify and speed up the transfection process.
The Company says that the CarriGene® Plates have been rigorously tested across a broad range of cell lines and transfection efficiency with superior cell viability in comparison with conventional reagent products on the market.
